Top Page
|
English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Thursday, October 31, 2024
Press Releases for Monday, September 12, 2022
Comprehensive Power Purchase Agreement Online Workshop is Now Open for Registration
17:24 HKT/SGT
Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma
14:37 HKT/SGT
HKTDC Hong Kong Watch & Clock Fair and Salon de TE conclude
14:00 HKT/SGT
AVIA Releases OTT Study in Singapore at its First OTT Upfront Showcase Presenting Premium Content at its Best
13:02 HKT/SGT
TOYOTA GAZOO Racing concludes a rocky Acropolis weekend
10:23 HKT/SGT
One-two home victory for TOYOTA GAZOO Racing
10:00 HKT/SGT
Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022
08:00 HKT/SGT
ACN Search:
RSS
News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Privacy Policy
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575
Connect With us: